MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-02-0040668
Biosafe Medicines Private Limited
Biosafe Medicines Private Limited - pharma in New Delhi, Delhi, India. Directors, charges & compliance details.
Revenue · FY 2024
₹61.29 Lakh
▲ 33% YoY
Net profit · FY 2024
₹39,710
Net margin 0.6%
EBITDA · FY 2024
₹1 Lakh
EBITDA margin 1.6%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹5 Lakh
Issued & subscribed
Company age
6 yrs
Est. 2020
Employees · EPFO
7
Provident fund records
Directors on board
3
As per MCA filings
About Biosafe Medicines Private Limited
Data last updated:
Biosafe Medicines Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 July 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24239DL2020PTC365729. Its GSTIN is 05AAJCB0865E1ZX (Uttarakhand).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Anil Kumar Pant and Vipin Sati.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 26 Veer Savarkar Block 660 Agarwal Chambers – III (Near Laxmi Nagar District Centre), New Delhi, Delhi, India – 110092.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.29 Lakh, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹39,710 (net margin 0.6%) and EBITDA of ₹1 Lakh (EBITDA margin 1.6%).
The company has about 7 employees on its provident fund (EPFO) records.
Court records list 3 cases involving the company, including 3 filed against it; 2 cases are pending.
Biosafe Medicines Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-02-0040668).
Company details
CIN U24239DL2020PTC365729
Registration Number 365729
Incorporation Date 07 July 2020
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-02-0040668
Recognitions & Rankings of Biosafe Medicines
Contact details
Biosafe Medicines Private Limited's registered office is in New Delhi, Delhi.
- Registered Address26 Veer Savarkar Block 660 Agarwal Chambers – III (Near Laxmi Nagar District Centre), New Delhi, Delhi, India – 110092
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Biosafe Medicines Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Biosafe Medicines is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Biosafe Medicines Private Limited, buy the company report.
Financials of Biosafe Medicines Private Limited
FY 2025 filings availableBiosafe Medicines Private Limited reported revenue of ₹61.29 Lakh (up 33% YoY) for FY 2024.
Revenue · FY 2024
₹61.29 Lakh ▲ 33%
Net profit · FY 2024
₹39,710 margin 0.6%
EBITDA · FY 2024
₹1 Lakh margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 33%
EBITDA CAGR growth
1 year
▲ 477%
3 years · compounded
▲ 57%
Revenue rose 33% in the latest year. EBITDA rose 477% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹1 Lakh | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹39,710 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 1.6% | |||
| Net Profit Margin | 0.6% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Biosafe Medicines Private Limited, buy the company report.
Board of directors of Biosafe Medicines Private Limited
Biosafe Medicines has 3 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anil Kumar Pant | Director | 07 Jul 2020 | 6 Years 3 Months | Current |
| Vipin Sati | Director | 07 Jul 2020 | 6 Years 3 Months | Current |
| Anurag Mishra | Director | 07 Jul 2020 | 6 Years 3 Months | Current |
Peer comparison
Biosafe Medicines Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Adtas Garments Private Limited | ₹61.47 Lakh (FY 2024) | -37.0% | Howrah, West Bengal, India | |||
| Reevon Industries India Limited | ₹61.41 Lakh (FY 2025) | 231.0% | Kolkata, West Bengal, India | |||
| Glasssutra Studio (OPC) Private Limited | ₹61.39 Lakh (FY 2025) | 46.0% | New Delhi, Delhi, India | |||
| Debhta Textiles Private Limited | ₹61.37 Lakh (FY 2025) | 156.0% | New Delhi, Delhi, India | |||
| Zennova Homes Private Limited | ₹61.33 Lakh (FY 2025) | 691385.0% | Jaipur, Rajasthan, India | |||
| Biosafe Medicines Private Limitedthis company | ₹61.29 Lakh (FY 2024) | ₹39,710 | 0.6% | 33.0% | New Delhi, Delhi, India | |
| Veerkrupa Synthetics Private Limited | ₹61.28 Lakh (FY 2025) | -44.0% | Surat, Gujarat, India | |||
| Mountview Vincom Private Limited | ₹61.23 Lakh (FY 2025) | -49.0% | Kolkata, West Bengal, India | |||
| Medarth Biotech Private Limited | ₹61.23 Lakh (FY 2025) | 77.0% | Nagpur, Maharashtra, India | |||
| Next Gen Secure Devices Private Limited | ₹61.19 Lakh (FY 2025) | -67.0% | Tirumangalam, Tamil Nadu, India | |||
| V Square Eximp Private Limited | ₹61.15 Lakh (FY 2025) | 0.0% | Pune, Maharashtra, India |
To see the full peer comparison of Biosafe Medicines Private Limited, buy the company report.
Legal cases
Biosafe Medicines Private Limited has 3 court cases on record: 3 filed against it. 2 cases are pending and 1 is disposed.
Total cases
3
Filed against the company
3
Pending
2
Disposed
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 3 | 2 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, South West, Delhi | Court case (CR CRIMINAL REVISION) | Filed against the company by Goodman Gilmans Life Sciences Pvt Ltd | Pending |
| District court, South West, Delhi | Criminal case | Filed against the company by Goodman Gilman's Life Sciences Pvt. Ltd. | Pending |
| District court, West, Delhi | Court case (Civ DJ) | Filed against the company by Goodman Gilmans Life Sciences Pvt Ltd | Disposed |
To see the full case history of Biosafe Medicines Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biosafe Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biosafe Medicines has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 05AAJCB0865E1ZX | Uttarakhand | Active | 30 Apr 2021 |
To see the full GST registrations and return filing status of Biosafe Medicines Private Limited, buy the company report.
Recent activity
Biosafe Medicines Private Limited has 3 board changes on record since 2020: 3 appointments. The latest: Anil Kumar Pant was appointed as Director on 07 Jul 2020.
AGM
Biosafe Medicines Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Biosafe Medicines Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Anil Kumar Pant was appointed as Director.
Appointed
Anurag Mishra was appointed as Director.
Appointed
Vipin Sati was appointed as Director.
Incorporation
07 Jul 2020
Biosafe Medicines Private Limited was registered on 07 Jul 2020 with Roc Delhi & aged 6 years 3 months as per MCA records.
Frequently asked questions
Biosafe Medicines is an active private limited company based in New Delhi, Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 July 2020 (6+ years old) and is registered under CIN U24239DL2020PTC365729.
Biosafe Medicines has 3 current directors:
- Anil Kumar Pant - Director
- Vipin Sati - Director
- Anurag Mishra - Director
The latest financial statements of Biosafe Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Biosafe Medicines is 05AAJCB0865E1ZX, registered in Uttarakhand.
The CIN (Corporate Identification Number) of Biosafe Medicines is U24239DL2020PTC365729. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biosafe Medicines has 3 court cases on record: 3 filed against it. 2 are pending.
Biosafe Medicines was incorporated on 07 July 2020, making it 6+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Biosafe Medicines by revenue are Adtas Garments Private Limited, Reevon Industries India Limited, Glasssutra Studio (OPC) Private Limited, Debhta Textiles Private Limited, Zennova Homes Private Limited and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Anil Kumar Pant was appointed as Director on 07 Jul 2020. Anurag Mishra was appointed as Director on 07 Jul 2020. Vipin Sati was appointed as Director on 07 Jul 2020.
Yes, Biosafe Medicines is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-02-0040668).
The registered office of Biosafe Medicines is at 26 Veer Savarkar Block 660 Agarwal Chambers – III Near Laxmi Nagar District Centre, New Delhi, Delhi, India – 110092.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages